ESC Premium Access

Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis

Congress Presentation

About the speaker

Doctor Mattia Zampieri

Careggi University Hospital (AOUC), Florence (Italy)
0 follower

4 more presentations in this session

Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records

Speaker: Doctor L. Anderson (London, GB)

Thumbnail

Usefulness of scintigraphy with [99mTc]Tc-DPD for the detection of transthyretin cardiac amyloidosis. Reference centre experience in an endemic area.

Speaker: Doctor N. Orta (Palma de Mallorca, ES)

Thumbnail

Cardiac magnetic resonance T1 imaging for the diagnosis of cardiac amyloidosis among patients with symptomatic heart failure

Speaker: Doctor R. Gessner (Leipzig, DE)

Thumbnail

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis

Speaker: Mr S. Muller (Utrecht, NL)

Thumbnail

Access the full session

Cardiac amyloidosis: my heart is filled with so much…

Speakers: Doctor M. Zampieri, Doctor L. Anderson, Doctor N. Orta, Doctor R. Gessner, Mr S. Muller
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations